BeyondSpring Pharmaceuticals to Present at the 4th Annual Evercore ISI HealthCONx Conference
NEW YORK, Nov. 24, 2021 (GLOBE NEWSWIRE) -- BeyondSpring (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global pharmaceutical company focused...
News
CENTOGENE Reports Third Quarter 2021 Financial Results
Second Consecutive Quarter of Core Business Growth, Phasing Out COVID-19 Testing and Restructuring Organization for Core Rare Disease BusinessCAMBRIDGE, Mass....
Valeo Pharma Announces $10 Million Bought Deal Private Placement of Convertible Debentures With Concurrent $10 Million Private Placement From Investissement Quebec
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS...
Revolution Medicines to Participate in 4th Annual Evercore ISI HealthCONx Conference
REDWOOD CITY, Calif., Nov. 24, 2021 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage precision oncology company focused...
PharmaTher Applies for FDA Orphan Drug Designation for Ketamine to Treat Rare Neurological Disorder Status Epilepticus
Adds to PharmaTher’s existing FDA orphan drug portfolio with amyotrophic lateral sclerosis and complex regional pain syndromeStrengthens commitment to treat...
Algernon Pharmaceuticals Announces Positive Feedback from U.S. FDA for Phase 1 Ifenprodil Small Cell Lung Cancer Study
VANCOUVER, British Columbia, Nov. 24, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW) (OTCQB:...
Oyster Point Pharma Announces Expansion of Executive Leadership Team to Support Commercialization of Tyrvaya™ (varenicline solution) Nasal Spray for the Signs and Symptoms of Dry Eye Disease
PRINCETON, N.J., Nov. 24, 2021 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc. (Nasdaq: OYST), a commercial-stage biopharmaceutical company focused on...
Anavex Life Sciences Provides Business Update and Reports Fiscal 2021 Year End Financial Results
Webcast and Conference Call Today at 4:30 p.m. Eastern TimeNEW YORK, Nov. 24, 2021 (GLOBE NEWSWIRE) -- Anavex Life Sciences...
Amicus Therapeutics to Present at the 4th Annual Evercore ISI HealthCONx Virtual Conference
PHILADELPHIA, Nov. 24, 2021 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that members of the Amicus senior leadership...
Avisa Diagnostics Reports on Status of Interim Filings
SANTA FE, N.M. and MALVERN, Pa., Nov. 24, 2021 (GLOBE NEWSWIRE) -- Avisa Diagnostics Inc. (CSE:AVBT) (“Avisa” or the “Company”),...
Better For You Wellness Announces Resignation of Director
Columbus, Ohio--(Newsfile Corp. - November 24, 2021) - Better For You Wellness, Inc. (OTC Pink: BFYW) ("Better For You Wellness"...
PreveCeutical Files Provisional Patent Application for D-Amino Acid Peptides
Vancouver, British Columbia--(Newsfile Corp. - November 24, 2021) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"),...
Therma Bright Launches Benepod.com eCommerce Website
The Innovative Hot & Cold Contrast Therapy Device for Relief of Chronic PainToronto, Ontario--(Newsfile Corp. - November 24, 2021) -...
Establishment Labs Announces Participation in the Stephens Annual Investment Conference
SANTA BARBARA, Calif.--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and...
Veracyte Announces Further European Reimbursement Expansion for Prosigna Breast Cancer Test
Only Test of Its Kind to Be Recommended for Use in All Swedish Healthcare Regions Without Restrictions SOUTH SAN FRANCISCO,...
Commercial New Launch of Dosell Together with Hepro AS in Norway
STOCKHOLM, SWEDEN / ACCESSWIRE / November 24, 2021 / iZafe Group (STO:IZAFE-B)Hepro AS has last issued a final approval of...
iZafe Group Invites Shareholders and Others to a Q&A Session Following The Publishing of The Third Quarter Report
STOCKHOLM, SWEDEN / ACCESSWIRE / November 24, 2021 / iZafe Group (STO:IZAFE-B)Stockholm, Sweden, iZafe Group AB (publ) ("iZafe" or "the...
Relief Therapeutics and InveniAI Sign a Strategic Collaboration Agreement to Identify New Product Development Opportunities using Artificial Intelligence
GENEVA, SWITZERLAND / ACCESSWIRE / November 24, 2021 / RELIEF THERAPEUTICS Holding SA (SIX:RLF, OTCQB:RLFTF, RLFTY) (" Relief "), announced...
Relief Reports that its U.S. Collaboration Partner has Announced the U.S. Food and Drug Administration has Denied Breakthrough Designation for Aviptadil
GENEVA, SWITZERLAND / ACCESSWIRE / November 24, 2021 / RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (" Relief...
VIVO Cannabis(TM) Announces Launch of Beacon Medical(TM) High-Dose CBD Oil and Pediatric Compassionate Care Program
Toronto, Ontario--(Newsfile Corp. - November 23, 2021) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company"), a leading...